These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 21841859)
21. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association. Mairesse GH; Braunschweig F; Klersy K; Cowie MR; Leyva F Europace; 2015 May; 17(5):814-8. PubMed ID: 25713012 [TBL] [Abstract][Full Text] [Related]
25. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism? Vollmann D; Lüthje L; Zabel M Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370 [No Abstract] [Full Text] [Related]
26. Pacing during a wide complex rhythm: implantable cardioverter defibrillator malfunction or not? Wood MA J Cardiovasc Electrophysiol; 2004 Jan; 15(1):114-5. PubMed ID: 15028085 [No Abstract] [Full Text] [Related]
27. Inappropriate shock because of triple counting in a patient with a subcutaneous implantable cardioverter defibrillator corrected by initiation of dual site left ventricular pacing. van Gelder BM; Bracke FA; Simmers T Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):239-40. PubMed ID: 25691559 [No Abstract] [Full Text] [Related]
28. Image Quality of Cardiac Magnetic Resonance Imaging in Patients With an Implantable Cardioverter Defibrillator System Designed for the Magnetic Resonance Imaging Environment. Schwitter J; Gold MR; Al Fagih A; Lee S; Peterson M; Ciuffo A; Zhang Y; Kristiansen N; Kanal E; Sommer T; Circ Cardiovasc Imaging; 2016 May; 9(5):. PubMed ID: 27151268 [TBL] [Abstract][Full Text] [Related]
29. An unusual case of impossible communication between an ICD and programmer. Attanasio P; Wutzler A; Huemer M; Parwani AS; Boldt LH; Haverkamp W; Blaschke F J Cardiovasc Electrophysiol; 2015 Feb; 26(2):230. PubMed ID: 25257919 [No Abstract] [Full Text] [Related]
30. Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study. Christensen AM; Bjerre J; Schou M; Jons C; Vinther M; Gislason GH; Johansen JB; Nielsen JC; Petersen HH; Riahi S; Ruwald AC Europace; 2019 Mar; 21(3):465-474. PubMed ID: 30535192 [TBL] [Abstract][Full Text] [Related]
31. Inadvertent implantable cardioverter defibrillator lead placement in the left ventricle: long-term follow-up at nine years and management by minimally-invasive surgery. Defaye P; Kane A; Jacon P; Obadia J Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):492-3. PubMed ID: 21172950 [TBL] [Abstract][Full Text] [Related]
32. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event?]. Oreziak A; Przybylski A Kardiol Pol; 2009 Aug; 67(8):930-1. PubMed ID: 19885986 [No Abstract] [Full Text] [Related]
33. Ethical issues on defibrillator deactivation in end-of-life patients. Facciorusso A; Stanislao M; Fanelli M; Valori VM; Valle G J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):498-500. PubMed ID: 21610508 [No Abstract] [Full Text] [Related]
34. Committed function for the first delivered shock of an uncommitted implantable cardioverter-defibrillator. Stroobandt RX; Barold SS Cardiol J; 2011; 18(5):570-2. PubMed ID: 21947997 [No Abstract] [Full Text] [Related]
35. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database. Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M; Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135 [TBL] [Abstract][Full Text] [Related]
36. Developing a crush: acute implantable cardioverter-defibrillator lead insulation break in a patient with multiple leads. Tilling L; Mason M Europace; 2014 Aug; 16(8):1196. PubMed ID: 25074973 [No Abstract] [Full Text] [Related]
37. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism? Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856 [No Abstract] [Full Text] [Related]
38. Performance of the Durata implantable cardioverter defibrillator lead: results of an independent multicenter study. Rordorf R; Taravelli E; Forleo GB; Giannola G; Calzolari V; Tadeo G; Rossi S; Vicentini A; Curnis A; Serra P; Santamaria M; Calò L J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):676-681. PubMed ID: 31343450 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry. Ricci RP; Morichelli L; D'Onofrio A; Calò L; Vaccari D; Zanotto G; Curnis A; Buja G; Rovai N; Gargaro A Europace; 2013 Jul; 15(7):970-7. PubMed ID: 23362021 [TBL] [Abstract][Full Text] [Related]